Literature DB >> 15681482

Complete gene scanning by temperature gradient capillary electrophoresis using the cystic fibrosis transmembrane conductance regulator gene as a model.

Lan-Szu Chou1, Friederike Gedge, Elaine Lyon.   

Abstract

Many inherited diseases involve large genes with many different mutations. Identifying a wide spectrum of mutations requires an efficient gene-scanning method. By differentiating thermodynamic stability and mobility of heteroduplexes from heterozygous samples, temperature gradient capillary electrophoresis (TGCE) was used to scan the entire coding region of the cystic fibrosis transmembrane conductance regulator gene. An initial panel (29 different mutations) showed 100% agreement between TGCE scanning and previously genotyped results for heterozygous samples. Different peak patterns were observed for single base substitutions and base insertions/deletions. Subsequently, 12 deidentified clinical samples genotyped as wild type for 32 mutations were scanned for the entire 27 exons. Results were 100% concordance with the bidirectional sequence analysis. Ten samples had nucleotide variations including a reported base insertion in intron 14b (2789 + 2insA) resulting in a possible mRNA splicing defect, and an unreported missense mutation in exon 20 (3991 G/A) with unknown clinical significance. This methodology does not require labeled primers or probes for detection and separation through a temperature gradient eliminates laborious temperature optimization required for other technologies. TGCE automation and high-throughput capability can be implemented in a clinical environment for mutation scanning with high sensitivity, thus reducing sequencing cost and effort.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681482      PMCID: PMC1867511          DOI: 10.1016/S1525-1578(10)60016-5

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  27 in total

1.  High-throughput detection of unknown mutations by using multiplexed capillary electrophoresis with poly(vinylpyrrolidone) solution.

Authors:  Q Gao; E S Yeung
Journal:  Anal Chem       Date:  2000-06-01       Impact factor: 6.986

2.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

3.  High-throughput methods for detection of genetic variation.

Authors:  V N Kristensen; D Kelefiotis; T Kristensen; A L Børresen-Dale
Journal:  Biotechniques       Date:  2001-02       Impact factor: 1.993

4.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.

Authors:  D G Wang; J B Fan; C J Siao; A Berno; P Young; R Sapolsky; G Ghandour; N Perkins; E Winchester; J Spencer; L Kruglyak; L Stein; L Hsie; T Topaloglou; E Hubbell; E Robinson; M Mittmann; M S Morris; N Shen; D Kilburn; J Rioux; C Nusbaum; S Rozen; T J Hudson; R Lipshutz; M Chee; E S Lander
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

5.  Worldwide genetic analysis of the CFTR region.

Authors:  E Mateu; F Calafell; O Lao; B Bonné-Tamir; J R Kidd; A Pakstis; K K Kidd; J Bertranpetit
Journal:  Am J Hum Genet       Date:  2000-12-04       Impact factor: 11.025

6.  Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations.

Authors:  P Jézéquel; C Dubourg; D Le Lannou; S Odent; J Y Le Gall; M Blayau; A Le Treut; V David
Journal:  Mol Hum Reprod       Date:  2000-12       Impact factor: 4.025

7.  Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.

Authors:  C Le Maréchal; M P Audrézet; I Quéré; O Raguénès; S Langonné; C Férec
Journal:  Hum Genet       Date:  2001-04       Impact factor: 4.132

8.  A sensitive scanning technology for low frequency nuclear point mutations in human genomic DNA.

Authors:  X C Li-Sucholeiki; W G Thilly
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

9.  Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency.

Authors:  J Walkowiak; K H Herzig; M Witt; A Pogorzelski; R Piotrowski; E Barra; A Sobczynska-Tomaszewska; M Trawinska-Bartnicka; K Strzykala; W Cichy; D Sands; E Rutkiewicz; M Krawczynski
Journal:  Eur J Clin Invest       Date:  2001-09       Impact factor: 4.686

10.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening.

Authors:  W W Grody; G R Cutting; K W Klinger; C S Richards; M S Watson; R J Desnick
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

View more
  5 in total

1.  Carbonic anhydrase-related protein VIII deficiency is associated with a distinctive lifelong gait disorder in waddles mice.

Authors:  Yan Jiao; Jian Yan; Yu Zhao; Leah Rae Donahue; Wesley G Beamer; Xinmin Li; Bruce A Roe; Mark S Ledoux; Weikuan Gu
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

2.  Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations.

Authors:  Friederike Gedge; Jamie McDonald; Amit Phansalkar; Lan-Szu Chou; Fernanda Calderon; Rong Mao; Elaine Lyon; Pinar Bayrak-Toydemir
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

3.  High resolution melting analysis for gene scanning.

Authors:  Maria Erali; Carl T Wittwer
Journal:  Methods       Date:  2010-01-18       Impact factor: 3.608

4.  Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.

Authors:  Edward J Michaud; Cymbeline T Culiat; Mitchell L Klebig; Paul E Barker; K T Cain; Debra J Carpenter; Lori L Easter; Carmen M Foster; Alysyn W Gardner; Z Y Guo; Kay J Houser; Lori A Hughes; Marilyn K Kerley; Zhaowei Liu; Robert E Olszewski; Irina Pinn; Ginger D Shaw; Sarah G Shinpock; Ann M Wymore; Eugene M Rinchik; Dabney K Johnson
Journal:  BMC Genomics       Date:  2005-11-21       Impact factor: 3.969

5.  Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.

Authors:  Issa Siryani; Mohamed Jama; Nisreen Rumman; Hiyam Marzouqa; Moein Kannan; Elaine Lyon; Musa Hindiyeh
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.